Dr. Edward Chang, a professor of neurosurgery at the University of California, San Francisco, said, "Very similar approaches might be relevant for other applications, such as treating symptoms of depression or anxiety," though the targets in the brain would be different.
These findings might be relevant for the development of sequence-based diagnostics and the design of agents to treat SARS.
The patient's past medical history was relevant for RA, treated from 1993 with gold salts, methotrexate, leflunomide, daily oral calcium and vitamin D3, and prednisone.
The last one, involving positions 63, 64, 65, 66, 67, 70, 72 (T5 in yellow on Figure 7B, numbered in Table 2) with a site volume of 252 Å and localized in the RT palm, is relevant for the treated set only.
The results of this study are relevant for people who treat or deal with eating disorders.
The patient's past medical history was relevant for rheumatoid arthritis, treated from 1995 with methotrexate, leflunomide, daily oral calcium, and vitamin D3 for 20 years and oral prednisone 0.1 mg/kg was added for the last 10 years.
Thus, these findings are relevant for clinicians who treat patients who have chronic constipation with concurrent abdominal symptoms and apply whether the clinician regards that patient as a CIC or an IBS-C patient.
Our aim was to especially focus on outcomes that are relevant for clinicians who treat patients with chronic depression, such as the response to treatment, remission, quality of life, and acceptance of treatments (dropout), and to further examine whether the addition of psychotherapy to a pharmacological intervention is more effective in certain subgroups of patients (e.g. according to diagnosis).
